Ozbay, M.F.; Harputluoglu, H.; Karaca, M.; Tekin, O.; Şendur, M.A.N.; Kaplan, M.A.; Sahin, B.; Geredeli, C.; Teker, F.; Tural, D.;
et al. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers 2024, 16, 3880.
https://doi.org/10.3390/cancers16223880
AMA Style
Ozbay MF, Harputluoglu H, Karaca M, Tekin O, Şendur MAN, Kaplan MA, Sahin B, Geredeli C, Teker F, Tural D,
et al. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers. 2024; 16(22):3880.
https://doi.org/10.3390/cancers16223880
Chicago/Turabian Style
Ozbay, Mehmet Fatih, Hakan Harputluoglu, Mustafa Karaca, Omer Tekin, Mehmet Ali Nahit Şendur, Muhammed Ali Kaplan, Berksoy Sahin, Caglayan Geredeli, Fatih Teker, Deniz Tural,
and et al. 2024. "Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes" Cancers 16, no. 22: 3880.
https://doi.org/10.3390/cancers16223880
APA Style
Ozbay, M. F., Harputluoglu, H., Karaca, M., Tekin, O., Şendur, M. A. N., Kaplan, M. A., Sahin, B., Geredeli, C., Teker, F., Tural, D., Saglam, S., Çil, T., Bilici, A., Erol, C., Kalkan, Z., Bayram, E., Selvi, O., Gültürk, İ., Göksu, S. S.,
& Tatlı, A. M.
(2024). Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers, 16(22), 3880.
https://doi.org/10.3390/cancers16223880
